THE EFFECT OF INTRAVENOUS PRETREATMENT WITH SMALL LIPOSOMES ON THE PHARMACOKINETICS AND METABOLISM OF ANTIPYRINE IN RABBITS

被引:1
作者
BADIOLA, N [1 ]
ALANGARY, ANA [1 ]
HALBERT, GW [1 ]
机构
[1] UNIV STRATHCLYDE,SCH PHARM & PHARMACOL,DEPT PHARM,ROYAL COLL BLDG,204 GEORGE ST,GLASGOW G1 1XW,SCOTLAND
关键词
D O I
10.1111/j.2042-7158.1992.tb03624.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of intravenous pre-treatment with empty small liposomes on the pharmacokinetics and metabolism of antipyrine in rabbits has been investigated. The measured half-life of antipyrine was 104 min and the volume of distribution was 830 mL kg-1. The excretion of metabolites in a 24 h urine sample was measured, the main metabolite 4-hydroxyantipyrine was excreted to a level of 10% with the free drug accounting for 4%. The norantipyrine and 3-hydroxymethylantipyrine metabolites were excreted to a level of 8 and 7%, respectively. The intravenous administration of liposomes at a dose equivalent to 8 mg of egg yolk phosphatidylcholine daily for one week, had no significant effect on any of the measured pharmacokinetic parameters. The half-life after liposome treatment was 110 min and the volume of distribution was 790 mL kg-1, the metabolic pattern in the urine was also unaltered. The results suggest that the repeated administration of low doses of liposomes do not affect the pharmacokinetics and metabolism of antipyrine.
引用
收藏
页码:366 / 368
页数:3
相关论文
共 20 条
  • [1] AL-ANGARY A, 1990, Journal of Pharmacy and Pharmacology, V42, p46P
  • [2] THE EFFECT OF NON-IONIC SURFACTANT VESICLE (NIOSOME) ENTRAPMENT ON THE ABSORPTION AND DISTRIBUTION OF METHOTREXATE IN MICE
    AZMIN, MN
    FLORENCE, AT
    HANDJANIVILA, RM
    STUART, JFB
    VANLERBERGHE, G
    WHITTAKER, JS
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (04) : 237 - 242
  • [3] BRECENRIDGE AM, 1990, COMPREHENSIVE MED CH, V5, P205
  • [4] EFFECTS OF DRUG PRETREATMENT ON ANTIPYRINE ELIMINATION IN THE RABBIT
    CHAMBERS, DM
    JEFFERSON, GC
    [J]. PHARMACOLOGY, 1982, 24 (02) : 88 - 95
  • [5] CONNEY AH, 1967, PHARMACOL REV, V19, P317
  • [6] INFLUENCE OF THE GENETICALLY CONTROLLED DEFICIENCY IN DEBRISOQUINE HYDROXYLATION ON ANTIPYRINE METABOLITE FORMATION
    DANHOF, M
    IDLE, JR
    TEUNISSEN, MWE
    SLOAN, TP
    BREIMER, DD
    SMITH, RL
    [J]. PHARMACOLOGY, 1981, 22 (06) : 349 - 358
  • [7] Davis SS, 1986, SITE SPECIFIC DRUG D, P93
  • [8] AN EXAMINATION OF A POSSIBLE PHARMACOKINETIC INTERACTION BETWEEN NIFEDIPINE AND ANTIPYRINE
    EDEKI, T
    JOHNSTON, A
    TURNER, P
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (04) : 405 - 407
  • [9] THE INCORPORATION OF LIPID-SOLUBLE ANTINEOPLASTIC AGENTS INTO MICROEMULSIONS PROTEIN-FREE ANALOGS OF LOW-DENSITY LIPOPROTEIN
    HALBERT, GW
    STUART, JFB
    FLORENCE, AT
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 21 (02) : 219 - 232
  • [10] LOPEZBERESTEIN G, 1989, UCLA S MOL CELLULAR, V89